# DESCRIPTION

## FIELD OF THE INVENTION

## BACKGROUND OF THE INVENTION

## OBJECT OF THE INVENTION

## SUMMARY OF THE INVENTION

## a) ID1, and

## c) ID2a.

## DETAILED DISCLOSURE OF THE INVENTION

### DEFINITIONS

### Preparation of VAR2CSA Polypeptides and Other Polypeptides of the Invention

### VAR2CSA Purification

### Combination Treatments

### Indications for Use of VAR2CSA Polypeptide and Conjugates Thereof

### Therapeutic or Diagnostic Effector Moiety, Such as Cytotoxic and Detecting Moieties

### Radionuclides

## EXAMPLES

### Production of Truncated Recombinant VAR2CSA Proteins

### VAR2CSA from FCR3 and 3D7 Binds CSA with Similar Affinity and Specificity

### The Core-CSA Binding Site Lies within the DBL2X Domain

### Antibodies Induced Against Novel Minimum Binding Regions Induce a Potent Parasite Anti-Adhesive Immune Response

### Example 5

## DISCUSSION

### Methods

